


產品信息
| 名稱 | SW626 (人卵巢癌細胞) (L15) (STR鑒定正確) (暫不出售) |
| 別稱 | SW-626; SW 626 |
| 背景描述 | The SW 626 cell line was initiated by A. Leibovitz in January 1974 at the Scott and White Clinic, Temple, Texas from a surgical specimen from a cystadenocarcinoma of the ovary in a 46 year old female Caucasian. Although originally thought to be of ovarian origin , a recent report has suggested that the SW 626 cell line might have been derived from an ovarian metastasis of a primary adenocarcinoma of the colon. |
| 種屬 | 人類 |
| 年齡(性別) | 女性,46歲 |
| 組織來源 | 子宮內膜腺癌組織 |
| 生長特性 | 貼壁細胞 |
| 細胞形態 | 上皮細胞樣 |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 卵巢癌細胞 |
| 生物安全等級 | 1 |
| 生長培養基 | Leibovitz's L-15+10% FBS+1% P/S |
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2~3次/周 |
| 凍存條件 | 凍存液:55% 基礎培養基+40%FBS+5%DMSO溫度:液氮 |
| 培養條件 | 氣相:空氣,100%溫度:37℃ |
| 致瘤性 | Yes, in nude mice produces well differentiated papillary adenocarcinomas consistent with ovarian primary. |
| 注意事項 | 1、該細胞推薦使用Leibovitz's L-15培養基進行培養,Leibovitz's L-15不可以通入二氧化碳,會產生細胞毒性; 2、如您沒有無二氧化碳的培養箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培養基時即可正常通入5%二氧化碳; 3、配套專用培養基默認Leibovitz's L-15配置,如需DMEM配方,請聯系銷售下單備注更改。 |
| 保藏機構 | ATCC; HTB-78 ECACC; 91091203 |
STR位點信息
| Amelogenin | X |
| CSF1PO | 11 |
| D2S1338 | 25 |
| D3S1358 | 15,17 |
| D5S818 | 12 |
| D7S820 | 12 |
| D8S1179 | 11 |
| D13S317 | 11 |
| D16S539 | 11 |
| D18S51 | 14 |
| D19S433 | 14 |
| D21S11 | 27,29 |
| FGA | 21,23 |
| PentaD | 9,13 |
| PentaE | 7,11 |
| TH01 | 9.3 |
| TPOX | 8 |
| vWA | 17,18 |
| D1S1656 | 15,17.3 |
| D6S1043 | 11 |
| D12S391 | 18,23 |